Beyond Conventional Antihypertensives: RNA Interference, Endothelin Antagonism, and Aldosterone-Synthase Inhibition in the Current Therapeutic Landscape
- DOI
- 10.1007/s40256-026-00830-8
- Published
- 2026-10-21
- Container
- American Journal of Cardiovascular Drugs
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s40256-026-00830-8,
title = {Beyond Conventional Antihypertensives: RNA Interference, Endothelin Antagonism, and Aldosterone-Synthase Inhibition in the Current Therapeutic Landscape},
author = {Giovanni Vincenzo Gaudio and Giuseppe Derosa and Giuseppe De Angelis and John Tremamondo and Alessandro Lupi},
year = {2026},
journal = {American Journal of Cardiovascular Drugs},
doi = {10.1007/s40256-026-00830-8},
url = {https://doi.org/10.1007/s40256-026-00830-8}
}RIS
TY - JOUR TI - Beyond Conventional Antihypertensives: RNA Interference, Endothelin Antagonism, and Aldosterone-Synthase Inhibition in the Current Therapeutic Landscape AU - Giovanni Vincenzo Gaudio AU - Giuseppe Derosa AU - Giuseppe De Angelis AU - John Tremamondo AU - Alessandro Lupi PY - 2026 JO - American Journal of Cardiovascular Drugs DO - 10.1007/s40256-026-00830-8 UR - https://doi.org/10.1007/s40256-026-00830-8 ER -
APA
Gaudio, G. V., Derosa, G., Angelis, G. D., Tremamondo, J., & Lupi, A. (2026). Beyond Conventional Antihypertensives: RNA Interference, Endothelin Antagonism, and Aldosterone-Synthase Inhibition in the Current Therapeutic Landscape. American Journal of Cardiovascular Drugs. https://doi.org/10.1007/s40256-026-00830-8
Source records
- crossref · retrieved 2026-11-10T14:23:57.865Z